The chikungunya epidemic has grown significantly in the Western hemisphere with an additional 3,000 cases worldwide during the past week.

In September 2014, the participating members of the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus (AMP RA/Lupus) Program funded a research Network to implement the program.

Ibuprofen has a corner on the over-the-counter pain market, accounting for one-third of OTC analgesics in the U.S.

Swiss drugmaker Roche Holding AG said on Monday the European Union has approved the use of its drug RoActemra in patients with early-stage rheumatoid arthritis.